Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors

Archives of Medical Research

Volumn 33, Issue 5, 2002, Pages 466-472

  Mejía, Ma Del Carmen ^a   Navarro, Samuel ^b   Pellín, Antonio ^b   Ruíz, Amparo ^b   Castel, Victoria ^c   Llombart Bosch, Antonio ^b  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Apoptosis; Neuroblastoma; Prognostic factors; Proliferation

Indexed keywords

CELL MARKER; KI 67 ANTIGEN; PEROXIDASE; PROTEIN BCL 2; PROTEIN P53;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER RISK; CANCER STAGING; CELL PROLIFERATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROPHORESIS; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SOUTHERN BLOTTING; STATISTICAL ANALYSIS;

APOPTOSIS; BLOTTING, SOUTHERN; CELL DIFFERENTIATION; CELL DIVISION; CHILD; CHILD, PRESCHOOL; DNA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; KI-67 ANTIGEN; MALE; MITOSIS; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036759979     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(02)00384-3     Document Type: Article

References (32)

1. Virchow R. Hyperplasie der zirbel und der nebennieren. Die krankhaften geschwultste. Vol. 2. 1865;Hirschwald, Berlin, Germany.
2. Schwab M., Varmus H.E., Bishop J.M. Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature. 308:1994;288-291.
3. Schleiermacher G., Peter M., Michon J., Hugot J., Vielh P., Zucker J., Magdelénat H., Thomas G., Delaterre O. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Genes Chromosomes Cancer. 20:1994;275-281.
4. Look T., Hayes A., Shuster J., Douglas E., Castleberry R., Bowman L., Smith E., Brodeur G. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma. a Pediatric Oncology Group Study J Clin Oncol. 9:1991;581-591.
5. Shimada H., Ambros I., Dehner L., Hata L.P., Josi V.V., Roald B., Stram D.O., Gerbing R.B., Lukens J.N., Matthay K.K., Castleberry R.P. The International Neuroblastoma Pathology Classification (the Shimada System). Cancer. 86:1999;364-372.
6. Kawasaki H., Mukai K., Yajima S., Tanaka R., Takayama J., Takasaki Y., Ohira M. Prognostic value of proliferating cell nuclear antigen (PCNA) Immunostaining in neuroblastoma. Med Pediatr Oncol. 24:1995;300-304.
7. Rudolph P., Lappe T., Hero B., Berthold F., Parwaresch R., Harms D., Schmidt D. Prognostic significance of the proliferative activity in neuroblastoma. Am J Pathol. 150:1997;133-145.
8. Castle V., Kathleen P., Bromberg J., Ou X., Dole M., Núñez G. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol. 143:1990;1543-1550.
9. Castel V., García-Miguel P., Melero C., Navajas A., Navarro S., Molina J., Badal M.D., Ruiz-Jiménez J., on behalf of the Spanish Neuroblastoma Study Group The treatment of advanced neuroblastoma. Results of the Spanish Neuroblastoma Study Group (SNSG) studies. Eur J Cancer. 4:1995;642-645.
10. Brodeur J.M., Seeger R.C., Barret A. International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma. J Clin Oncol. 6:1988;1874-1881.
11. Shimada H., Chatten J., Newton W.A., Sachs N., Hamoud A., Chiba T., Marsden H., Misugi K. Histopathologic prognostic factors in neuroblastic tumors. definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas J Natl Cancer Inst. 73:1984;405-416.
12. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase techniques. a comparison between ABC and unlabeled antibody (PAP) procedures J Histochem Cytochem. 29:1981;577-580.
13. Cattoretti G., Pileri S., Parraviccini C., Becker M., Poggi S., Biulco C., Key G., D'Amato L., Sabattini E., Feudale E., Reynolds F., Gerde J., Rilke F. Antigen unmasked on formalin-fixed, paraffin-embedded tissue sections. J Pathol. 171:1993;83-98.
14. Sambrook J., Fritsch E.F., Maniatis T. Analysis of genomic DNA Southern hybridization. Nolan C., Ford N., Ferguson M. Molecular cloning. a laboratory manual:1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA. 9-31.p.
15. Crabbe D.C.G., Peters J., Seeger R.C. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Diag Mol Pathol. 1:1992;229-234.
16. Norusis M. SPSS Base for Windows. Version 6.0. User's Guide. Chicago, IL, USA: SPPS, Inc.;1994. p. 333.
17. Schwartz D. La prueba de X2 y la comparación de varias repeticiones observadas. Problema general de relación entre dos caracteres cualitativos. Schwartz D. Estadística para biólogos y médicos. 1991;Editorial Heder, Barcelona, Spain. 87-105.pp.
18. Saito T., Tsunematsu Y., Saeki M., Honna T., Masaki E., Kojima Y., Miyauchi J. Trends of survival in neuroblastoma and independent risk factors for survival at a single institution. Med Pediatr Oncol. 29:1997;197-205.
19. Castel V, Cañete A, García-Miguel P. Change in age and stage distribution of neuroblastoma patients in Spain. Localized Neuroblastoma and 4th International Symposium on Neuroblastoma Screening. 1995. Stuttgart, Germany.
20. López F., Belloc F., Lambe F., Dumain P., Feiffers J., Bernard P., Boisseau M. The labeling of proliferating cells by Ki-67 and Mib-1 antibodies depends on the binding of a nuclear protein to the DNA. Exp Cell Res. 210:1994;145-153.
21. Hanada M., Krajewski S., Tanaka S., Cazals-Hatem D., Spengler B., Ross R., Biedler J., Reed J. Regulation of bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res. 53:1993;4978-4986.
22. Weinreb M., Day P.J.R., Niggli F., Raafat F., Mann J. BCL-2 oncoprotein in neuroblastoma. Lancet. 345:1995;992-993.
23. Bissonnette R., Echeverri F., Mahoubi A., Green D. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359:1992;552-554.
24. Koizumi H., Ohkawa I., Uchikoshi T., Nakada K. Expression of the apoptosis regulatory proteins, fas, fas ligand and caspase-3 in primary neuroblastoma tissues. Med Pediatr Oncol. 31:1998;228-234.
25. Nigro J.M., Baker S.J., Preinsinger A.C., Jessup J.M., Hostetter R., Cleary K., Bigner S.H., Davidson N., Baylin S., Devilee P. Mutations in the p53 gene occur in diverse human tumor types. Nature. 342:1989;705-708.
26. Hollstein M., Shomer B., Greenblatt M., Soussi T., Hoving E., Montesano R., Harris C.C. Somatic point mutations in the p53 gene of human tumors and cell lines. update compilation Nucleic Acid Res. 24:1996;141-146.
27. Knudson C.M., Tung K.S.K., Tourtellotte W.G., Brown G.A., Korsmeyer S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science. 270:1995;96-99.
28. Selvakumaran M., Lin H.K., Miyashita T., Wang H.G., Krajewski S., Reed J.C., Hoffman B., Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGF beta 1. a paradigm for distinct apoptotic pathways Oncogene. 9:1994;1791-1798.
29. Schott A.F., Apel I.J., Núñez G., Clarke M.F. Bcl-xL protects cancer cells from p53-mediated apoptosis. Oncogene. 11:1995;1389-1394.
30. Mejía C., Pellín A., Navarro S., Castel V., Llombart-Bosch A. A new mutation of the p53 gene in human neuroblastoma, not correlated with N-myc amplification. Int J Surg Pathol. 7:1999;149-154.
31. Levine A. The p53 tumor-suppressor gene. N Engl J Med. 326:1992;1350-1352.
32. Mejía C., Navarro S., Pellín A., Castel V., Llombart-Bosch A. Study of bcl-2 protein expression and the apoptosis phenomenon in neuroblastoma. Anticancer Res. 18:1998;801-806.